Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases

Keiko Fujii, Masako Aoyama, Katsuji Shinagawa, Keitaro Matsuo, Katsuto Takenaka, Kazuma Ikeda, Kensuke Kojima, Fumihiko Ishimaru, Katsuyuki Kiura, Hiroshi Ueoka, Kenji Niiya, Mitsune Tanimoto, Mine Harada

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Autologous peripheral blood stem cell transplantation (auto-PBSCT) has facilitated high-dose chemotherapy for the treatment of various types of malignancy, but the factors affecting the treatment outcome have not been well defined. We evaluated patients who underwent auto-PBSCT (46 patients with hematological malignancies and 39 with solid tumors) to elucidate the risks of background factors, including age, in association with infectious complications. In contrast to former reports, faster engraftment did not influence the incidence of documented infection or neutropenic fever, whereas high age (age ≥50 years old) and delayed platelet recovery (≥18 days) were demonstrated to be positively involved. The odds ratio (OR) for documented infection in elderly patients was 4.94 (95% confidence interval, 1.22-15.8). Another risk factor of infection was the HD-ICE regimen (ifosfamide, carboplatin, etoposide) given to patients with solid tumors (OR, 8.00; 95% confidence interval, 1.61-39.7). In conclusion, we found that elderly patients and patients on the HD-ICE regimen have a higher risk of infectious complications even after auto-PBSCT. Although the clinical indications for auto-PBSCT can be extended to elderly patients, thorough precautions should be taken against infectious complications during the pre-engraftment phase.

Original languageEnglish
Pages (from-to)186-191
Number of pages6
JournalInternational journal of hematology
Volume76
Issue number2
DOIs
Publication statusPublished - Aug 1 2002

Fingerprint

Peripheral Blood Stem Cell Transplantation
Fever
Infection
Odds Ratio
Confidence Intervals
Neoplasms
Ifosfamide
Carboplatin
Etoposide
Hematologic Neoplasms
Blood Platelets
Drug Therapy
Incidence

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases. / Fujii, Keiko; Aoyama, Masako; Shinagawa, Katsuji; Matsuo, Keitaro; Takenaka, Katsuto; Ikeda, Kazuma; Kojima, Kensuke; Ishimaru, Fumihiko; Kiura, Katsuyuki; Ueoka, Hiroshi; Niiya, Kenji; Tanimoto, Mitsune; Harada, Mine.

In: International journal of hematology, Vol. 76, No. 2, 01.08.2002, p. 186-191.

Research output: Contribution to journalArticle

Fujii, K, Aoyama, M, Shinagawa, K, Matsuo, K, Takenaka, K, Ikeda, K, Kojima, K, Ishimaru, F, Kiura, K, Ueoka, H, Niiya, K, Tanimoto, M & Harada, M 2002, 'Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases', International journal of hematology, vol. 76, no. 2, pp. 186-191. https://doi.org/10.1097/00003086-200210000-00027
Fujii, Keiko ; Aoyama, Masako ; Shinagawa, Katsuji ; Matsuo, Keitaro ; Takenaka, Katsuto ; Ikeda, Kazuma ; Kojima, Kensuke ; Ishimaru, Fumihiko ; Kiura, Katsuyuki ; Ueoka, Hiroshi ; Niiya, Kenji ; Tanimoto, Mitsune ; Harada, Mine. / Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases. In: International journal of hematology. 2002 ; Vol. 76, No. 2. pp. 186-191.
@article{621b34fd4a0d476ba5f5c7e951e280e8,
title = "Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases",
abstract = "Autologous peripheral blood stem cell transplantation (auto-PBSCT) has facilitated high-dose chemotherapy for the treatment of various types of malignancy, but the factors affecting the treatment outcome have not been well defined. We evaluated patients who underwent auto-PBSCT (46 patients with hematological malignancies and 39 with solid tumors) to elucidate the risks of background factors, including age, in association with infectious complications. In contrast to former reports, faster engraftment did not influence the incidence of documented infection or neutropenic fever, whereas high age (age ≥50 years old) and delayed platelet recovery (≥18 days) were demonstrated to be positively involved. The odds ratio (OR) for documented infection in elderly patients was 4.94 (95{\%} confidence interval, 1.22-15.8). Another risk factor of infection was the HD-ICE regimen (ifosfamide, carboplatin, etoposide) given to patients with solid tumors (OR, 8.00; 95{\%} confidence interval, 1.61-39.7). In conclusion, we found that elderly patients and patients on the HD-ICE regimen have a higher risk of infectious complications even after auto-PBSCT. Although the clinical indications for auto-PBSCT can be extended to elderly patients, thorough precautions should be taken against infectious complications during the pre-engraftment phase.",
author = "Keiko Fujii and Masako Aoyama and Katsuji Shinagawa and Keitaro Matsuo and Katsuto Takenaka and Kazuma Ikeda and Kensuke Kojima and Fumihiko Ishimaru and Katsuyuki Kiura and Hiroshi Ueoka and Kenji Niiya and Mitsune Tanimoto and Mine Harada",
year = "2002",
month = "8",
day = "1",
doi = "10.1097/00003086-200210000-00027",
language = "English",
volume = "76",
pages = "186--191",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases

AU - Fujii, Keiko

AU - Aoyama, Masako

AU - Shinagawa, Katsuji

AU - Matsuo, Keitaro

AU - Takenaka, Katsuto

AU - Ikeda, Kazuma

AU - Kojima, Kensuke

AU - Ishimaru, Fumihiko

AU - Kiura, Katsuyuki

AU - Ueoka, Hiroshi

AU - Niiya, Kenji

AU - Tanimoto, Mitsune

AU - Harada, Mine

PY - 2002/8/1

Y1 - 2002/8/1

N2 - Autologous peripheral blood stem cell transplantation (auto-PBSCT) has facilitated high-dose chemotherapy for the treatment of various types of malignancy, but the factors affecting the treatment outcome have not been well defined. We evaluated patients who underwent auto-PBSCT (46 patients with hematological malignancies and 39 with solid tumors) to elucidate the risks of background factors, including age, in association with infectious complications. In contrast to former reports, faster engraftment did not influence the incidence of documented infection or neutropenic fever, whereas high age (age ≥50 years old) and delayed platelet recovery (≥18 days) were demonstrated to be positively involved. The odds ratio (OR) for documented infection in elderly patients was 4.94 (95% confidence interval, 1.22-15.8). Another risk factor of infection was the HD-ICE regimen (ifosfamide, carboplatin, etoposide) given to patients with solid tumors (OR, 8.00; 95% confidence interval, 1.61-39.7). In conclusion, we found that elderly patients and patients on the HD-ICE regimen have a higher risk of infectious complications even after auto-PBSCT. Although the clinical indications for auto-PBSCT can be extended to elderly patients, thorough precautions should be taken against infectious complications during the pre-engraftment phase.

AB - Autologous peripheral blood stem cell transplantation (auto-PBSCT) has facilitated high-dose chemotherapy for the treatment of various types of malignancy, but the factors affecting the treatment outcome have not been well defined. We evaluated patients who underwent auto-PBSCT (46 patients with hematological malignancies and 39 with solid tumors) to elucidate the risks of background factors, including age, in association with infectious complications. In contrast to former reports, faster engraftment did not influence the incidence of documented infection or neutropenic fever, whereas high age (age ≥50 years old) and delayed platelet recovery (≥18 days) were demonstrated to be positively involved. The odds ratio (OR) for documented infection in elderly patients was 4.94 (95% confidence interval, 1.22-15.8). Another risk factor of infection was the HD-ICE regimen (ifosfamide, carboplatin, etoposide) given to patients with solid tumors (OR, 8.00; 95% confidence interval, 1.61-39.7). In conclusion, we found that elderly patients and patients on the HD-ICE regimen have a higher risk of infectious complications even after auto-PBSCT. Although the clinical indications for auto-PBSCT can be extended to elderly patients, thorough precautions should be taken against infectious complications during the pre-engraftment phase.

UR - http://www.scopus.com/inward/record.url?scp=0142044896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142044896&partnerID=8YFLogxK

U2 - 10.1097/00003086-200210000-00027

DO - 10.1097/00003086-200210000-00027

M3 - Article

C2 - 12215019

AN - SCOPUS:0142044896

VL - 76

SP - 186

EP - 191

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 2

ER -